MYXREDLIN 1 [iU]/mL
insulin human · INJECTION, SOLUTION · Baxter Healthcare Corporation
No Recall HistoryCurrently in Shortage
Plain English
MYXREDLIN is a injection, solution containing insulin human at 1 [iU]/mL, taken intravenous. Manufactured by Baxter Healthcare Corporation.
Key Facts
- Brand Name
- MYXREDLIN
- Generic Name
- insulin human
- NDC Code (Product)
0338-0126- Manufacturer
- Baxter Healthcare Corporation
- Strength
- 1 [iU]/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA208157
- Drug Class
- Insulin [EPC]
- Marketing Start
- 07/12/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is MYXREDLIN used for?
MYXREDLIN contains insulin human. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is MYXREDLIN a controlled substance?
MYXREDLIN is not classified as a controlled substance by the DEA.
What is the generic name for MYXREDLIN?
The generic name for MYXREDLIN is insulin human. There are 11 other brand versions of insulin human.
What is the NDC code for MYXREDLIN 1 [iU]/mL?
The NDC (National Drug Code) for MYXREDLIN 1 [iU]/mL is 0338-0126, listed by Baxter Healthcare Corporation.